Suvorexant: a promising, novel treatment for insomnia
Joyce K Lee-Iannotti,1 James M Parish2 1Division of Neurology, Sleep Disorders Center, Banner University Medical Center, Phoenix, AZ, USA; 2Division of Pulmonary Medicine, Center for Sleep Medicine, Mayo Clinic, Phoenix, AZ, USA Abstract: Suvorexant a novel, orexin receptor antagonist was recently...
Guardado en:
Autores principales: | Lee-Iannotti JK, Parish JM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0c588f9105d42cc928f5aef83bf3bb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman JL, et al.
Publicado: (2016) -
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
por: Rosenberg R, et al.
Publicado: (2021) -
Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients
por: Firouzabadi N, et al.
Publicado: (2020) -
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016) -
Brief behavioral treatment for patients with treatment-resistant insomnia
por: Wang J, et al.
Publicado: (2016)